Are cancer stem cells the sole source of tumor?
10.1007/s11596-014-1327-8
- Author:
Min HU
1
;
Fei-Xiang XIANG
;
Yu-Fei HE
Author Information
1. Department of Cardiothoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China, huminchn@sina.com.
- Publication Type:Journal Article
- MeSH:
Algorithms;
Animals;
Carcinogenesis;
pathology;
Carcinoma, Lewis Lung;
pathology;
Cell Differentiation;
Cell Line, Tumor;
Cell Proliferation;
Liver Neoplasms, Experimental;
pathology;
Melanoma, Experimental;
pathology;
Mice, Inbred BALB C;
Mice, Inbred C57BL;
Models, Biological;
Neoplasms, Experimental;
pathology;
Neoplastic Stem Cells;
pathology;
Time Factors;
Tumor Stem Cell Assay;
methods
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2014;34(5):621-625
- CountryChina
- Language:English
-
Abstract:
Tumors are believed to consist of a heterogeneous population of tumor cells originating from rare cancer stem cells (CSCs). However, emerging evidence suggests that tumor may also originate from non-CSCs. To support this viewpoint, we are here to present definitive evidence indicating that the number of tumorigenic tumor cells is greater than that of CSCs in tumor, and tumor can also derive from non-CSCs. To achieve this, an idealized mathematical model was employed in the present study and theoretical calculation revealed that non-CSCs could initiate the occurrence of tumor if their proliferation potential was adequate. Further, experimental studies demonstrated that 17.7%, 38.6% and 5.2% of tumor cells in murine B16 solid melanoma, H22 hepatoma and Lewis lung carcinoma, respectively, were potentially tumorigenic. Thus, based on the aforementioned findings, we propose that the scarce CSCs, if exist, are not the sole source of a tumor.
